Lower syringe sharing and re-use after syringe legalization in Rhode Island

Drug and Alcohol Dependence

Volumn 89, Issue 2-3, 2007, Pages 292-297

  Rich, Josiah D ^a,b   Hogan, Joseph W ^b   Wolf, Francis ^c   DeLong, Allison ^b   Zaller, Nickolas D ^a   Mehrotra, Meenakshi ^d   Reinert, Steven ^a  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

HIV; HIV prevention; Injection drug use; Needles; Syringes

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; DRUG DETOXIFICATION; DRUG USE; HOSPITAL PATIENT; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; LAW; POLICY; PRIORITY JOURNAL; SYRINGE; UNITED STATES; VIRUS TRANSMISSION;

CROSS-SECTIONAL STUDIES; EQUIPMENT REUSE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MASSACHUSETTS; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; RHODE ISLAND; RISK FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34248597141     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.02.016     Document Type: Article

References (24)

1. Angrist J.D., Imbens G.W., and Rubin D.B. Identification of causal effects using instrumental variables. J. Am. Stat. Assoc. 91 (1996) 444-472
2. Broadhead R.S., van Hulst Y., and Heckathorn D.D. The impact of a needle exchange's closure. Public Health Rep. 114 5 (1999) 439-447
3. Burris S., Vernick J.S., Ditzler A., and Strathdee S. The legality of selling or giving syringes to injection drug users. J. Am. Pharm. Assoc. (Wash) 42 6 Suppl. 2 (2002) S13-S18
4. Case P., Meehan T., and Jones T.S. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 Suppl. 1 (1998) S71-S75
5. Centers for Disease Control and Prevention, 2002a. IDU HIV prevention: access to sterile syringes.
6. Centers for Disease Control and Prevention, 2002b. IDU HIV prevention: viral hepatitis and injection drug users.
7. Centers for Disease Control and Prevention, 2002c. IDU HIV prevention: policy efforts to increase IDU's access to sterile syringes.
8. Centers for Disease Control Prevention. AIDS associated with injecting-drug use-United States. Morb. Mortal Wkly. Rep., 1996 45 19 (1995) 392-398
9. Des Jarlais D.C., McKnight C., and Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. J. Am. Pharm. Assoc. (Wash) 42 6 Suppl. 2 (2002) S73-S76
10. Friedland G., and Selwyn P. Infectious (excluding AIDS) in injection drug users. In: Longo D.L. (Ed). Harrison's Principles of Internal Medicine. 14th ed. (1998), McGraw-Hill, New York 831-835
11. Friedman S.R., Perlis T., and Des Jarlais D.C. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am. J. Public Health 91 5 (2001) 654-791
12. Holmberg S.D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 86 5 (1996) 642-654
13. Lurie P., and Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 349 9052 (1997) 604-608
14. McKnight M.C., Des Jarlais D.C., Perlis T., et al. Update: syringe exchange programs-United States. Morb. Mortal Wkly. Rep., 2005 54 27 (2002) 673-676
15. Normand J., Vlahov D., and Moses L.E. Preventing HIV Transmission: The Role of Sterile Needles and Bleach (1995), National Academies Press, Washington, DC
16. Novotny G.A., Cotton-Oldenburg N.U., Bond B., and Tracy B. The Minnesota pharmacy syringe access initiative: a successful statewide program to increase injection drug user access to sterile syringes. J. Am. Pharm. Assoc. (Wash) 42 6 Suppl. 2 (2002) S21-S22
17. Reich W., Compton W.M., Horton J.C., et al. Injection drug users report good access to pharmacy sale of syringes. J. Am. Pharm. Assoc. (Wash) 42 6 Suppl. 2 (2002) S68-S72
18. Rich J.D., Dickinson B.P., Liu K.L., Case P., Jesdale B., Ingegneri R.M., and Nolan P.A. Strict syringe laws in Rhode Island are associated with high rates of re-using syringes and HIV risks among injection drug users. J. AIDS Hum. Retro. 18 Suppl. 1 (1998) S140-S141 (letter)
19. Rich J.D., Strong L.L., Mehrotra M., and Macalino G. Strategies to optimize the impact of needle exchange programs. AIDS Read. 10 7 (2000) 421-429
20. Rich J.D., Macalino G.E., McKenzie M., Taylor L.E., and Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am. J. Public Health 91 5 (2001) 699-700
21. Rich J.D., Martin E.G., Macalino G.E., Paul R.V., McNamara S., and Taylor L.E. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J. Am. Pharm. Assoc. (Wash) 42 6 Suppl. 2 (2002) S58-S61
22. Rich J.D., Dokson L., and Dickinson B.P. The economic cost of strict syringe control. Med. Health RI. 81 6 (1998) 207-208
23. Stancliff S., Agins B., Rich J.D., and Burris S. Syringe access for the prevention of bloodborne infections among injection drug users. BMC Public Health 3 1 (2003) 37
24. Taussig J.A., Weinstein B., Burris S., and Jones T.S. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS 14 Suppl. 1 (2000) S47-S51